NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Sanjay Malkani

Sanjay Malkani is the Global President of Lab Solutions for LumiraDx, overseeing a team that is disrupting the Molecular Lab Testing industry with rapid lab reagent solutions. He is also a founder and Director of GenePace Laboratories in Indianapolis, and a Director of Omega Laboratories, with sites in the US and Canada. He brings over two decades of experience in leading and growing Global diagnostic businesses.​

For the decade ending Q1’18, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global leader in diversified toxicology products, services and rapid diagnostics.  Sanjay was a platform consolidator and grew the business from ~$50MM to ~$650MM, deploying ~$1.1B into over 30 merged assets to form a stand-alone division of 2,500+ employees across all major world regions, delivering on significant value creation as measured by a leading Global strategy and Board advisory firm. ​

As a named executive officer and member of the company’s executive team, he supported Alere’s $5.3 billion sale to Abbott Laboratories, Inc (NYSE: ABT) in 2017.  ​

Sanjay has executive experience across diversified In-Vitro Diagnostics platforms – including Biologics, Point-of-Care Diagnostics, Laboratory Services and Health Information Solutions – and has developed the world-leading business in every healthcare category he has worked in. He held successive executive and commercial leadership positions within the Point-of-Care and Diabetes Care divisions of Roche Diagnostics, Inc. from 2001 to 2008, and within the Specialty Chemicals division of Dow Chemical, Inc. ​

Sanjay holds an MBA from the Kellogg School at Northwestern University (1998) and an undergraduate degree in Industrial Engineering from Purdue University (1991).  ​

Contact Information

  • Sanjay.Malkani@lumiradx.com
  • c: 317.645.7636

Comments are closed.